InvestorsHub Logo
Followers 50
Posts 8785
Boards Moderated 0
Alias Born 09/21/2004

Re: abbam post# 19025

Friday, 05/02/2008 3:18:22 PM

Friday, May 02, 2008 3:18:22 PM

Post# of 35633
Re: "i would think FDA approval will speak for itself. And not $3.00, i am thinking alot more."

Other shareholders and I are suggesting CTGI should probably be near $3.00 now, before FDA approval (as nellio73 says), just on strength of what CSMG has going for it. We are, of course, concerned about dilution if co. must raise more private capital at lower stock prices. Company arguably spending a lot of money these days. For example, in order to feed itself, CSMG privately sold 1,347,766 shs @ ave $0.615--a 38% discount to closing ave market price of $.995. This on 17/18 Oct 2007. A lower stock price base also delimits upside once FDA approval lever is tripped.




These are my opinions and sentiments only. Take them for what they're worth. Do your DD. Buying stocks is risky!

"If we could sell our experiences for what they cost us, we'd all be millionaires." -Abigail van Buren (a/k/a Dear Abby)

Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.